ScholarLens Back to search
2020•Journal watchRequires access

Maintenance Immunotherapy for Myelin Oligodendrocyte Glycoprotein–Associated Antibody Disease

Robert T. Naismith

Open publisher page 0 citations

Abstract

Neuromyelitis optica spectrum disorder (NMOSD) can be associated with myelin oligodendrocyte glycoprotein (MOG) antibody, other antibodies, or no

About this research paper

What this paper is about

Neuromyelitis optica spectrum disorder (NMOSD) can be associated with myelin oligodendrocyte glycoprotein (MOG) antibody, other antibodies, or no

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Neuromyelitis optica spectrum disorder (NMOSD) can be associated with myelin oligodendrocyte glycoprotein (MOG) antibody, other antibodies, or no

Key concepts: Myelin oligodendrocyte glycoprotein, Medicine, Immunotherapy, Antibody, Glycoprotein, Oligodendrocyte, Immunology, Myelin

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Maintenance Immunotherapy for Myelin Oligodendrocyte Glycoprotein–Associated Antibody Disease — Research Paper | ScholarLens